Wednesday June 10, 2026
Place your advertisement here.
Contact us today +2207336467/5035263
.
GCRPS Logo
Place your advertisement here.
Contact us today +2207336467/5035263
GRA Image
Place your advertisement here.
Contact us today +2207336467/5035263

Islamic Development Bank Institute (IsDBI) Launches eBook Reader App Review Competition

PRESS RELEASE

JEDDAH, Saudi Arabia, November 27, 2025/ — The Islamic Development Bank Institute (https://IsDBInstitute.org/) is pleased to announce the launch of a Competition of the IsDBI eBook Reader App Review. The Reader offers the access to the Institute’s extensive collection of publications in Islamic economics and finance on its online bookstore (https://IsDBInstitute.org/publication).

We invite users to share their experiences and feedback as part of a major initiative to enhance the user experience and performance of the Reader.

Participants in the competition stand the opportunity to win generous cash awards:

  • First Prize:  US$1,500
  • Second Prize: US$1,000
  • Third Prize: US$700

The competition also offers an opportunity for participants to influence the future of digital access to knowledge in Islamic economics and finance, and gain recognition for their insights and contributions.

The IsDBI eBook Reader App was released in 2022, available for iOS and Android smart devices, and as a web-based cloud version for all supported browsers. This competition aims to promote user engagement and collect qualitative feedback for further enhancements of the Reader.

More information on the Reader and how to download/access it is available here: https://IsDBInstitute.org/ebook-reader-application/

Participants in this competition are expected to submit a written review essay (about 700-1,000 words) of their experience using the Reader, addressing the following aspects: ease of use; interface/navigation; speed; reading features (bookmarking, highlighting, etc.); and library.

We invite users to submit their reviews by email to [email protected] (with copy to [email protected]) by 15 January 2026.

Full details on the competition are available on IsDBI website here: https://IsDBInstitute.org/ebook-reader-application/

Distributed by APO Group on behalf of Islamic Development Bank Institute (IsDBI).

Social media handles:
X (Twitter):https://apo-opa.co/4rmrCQD
Facebook: https://apo-opa.co/4rvJOrp
LinkedIn: https://apo-opa.co/48CJ7oz

About the Islamic Development Bank Institute:
The Islamic Development Bank Institute (IsDBI) is the knowledge beacon of the Islamic Development Bank Group. Guided by the principles of Islamic economics and finance, the IsDB Institute leads the development of innovative knowledge-based solutions to support the sustainable economic advancement of IsDB Member Countries and various Muslim communities worldwide. The IsDB Institute enables economic development through pioneering research, human capital development, and knowledge creation, dissemination, and management. The Institute leads initiatives to enable Islamic finance ecosystems, ultimately helping Member Countries achieve their development objectives. More information about the IsDB Institute is available on https://IsDBInstitute.org/

SOURCE
Islamic Development Bank Institute (IsDBI)

Sign up to receive the latest news and events in your inbox

Join our community of news enthusiasts.

Breaking News in your inbox

Sign up to receive latest news and events in your inbox.

Share the news with your Friends and Family

Related News

Saudi Deputy Foreign Minister Meets Iranian FM in Tehran

TEHRAN (Tasnim) – Saudi Arabia’s Deputy Foreign Minister Saud bin Mohammed Al-Sati met with Iranian Foreign Minister Abbas Araqchi in Tehran on Sunday, according to Iran’s Foreign Ministry. The ministry said that the meeting was part of ongoing diplomatic consultations between the two Muslim states. It said that the talks focused on bilateral relations and

Share the news with your Friends and Family

China approves first-ever functional cure for hepatitis B

By:Justus Hartmann China has approved the world’s first drug aimed at a functional cure of hepatitis B — a disease that affects more than 250 million people worldwide. The new therapy, Pegbing, developed by Amoytop Biotech in Xiamen, marks a breakthrough after decades of treatments that could control the virus but rarely silence it. A

Share the news with your Friends and Family
ARPS Media
ARPS Media

FREE
VIEW